Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Pooja Karukonda"'
Autor:
Pooja Karukonda, Fumiko Chino
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 116:154-156
Autor:
Saumendra N. Sarkar, Greg M. Delgoffe, Christopher J. Bakkenist, Hassane M. Zarour, Veit Hornung, Stephen H. Thorne, Pooja Karukonda, Joe-Marc Chauvin, Yiyang Wang, Ashley V. Menk, Chandra Nath Roy, Rashmi Srivastava, Frank P. Vendetti, Nicole E. Scharping, Weizhou Hou, Lulu Shao
Multiple studies have associated the transcription factor IRF1 with tumor-suppressive activities. Here, we report an opposite tumor cell–intrinsic function of IRF1 in promoting tumor growth. IRF1-deficient tumor cells showed reduced tumor growth in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a56b6cc559cb7e26d9a33e1e0d6618a
https://doi.org/10.1158/2326-6066.c.6549892
https://doi.org/10.1158/2326-6066.c.6549892
Autor:
Saumendra N. Sarkar, Greg M. Delgoffe, Christopher J. Bakkenist, Hassane M. Zarour, Veit Hornung, Stephen H. Thorne, Pooja Karukonda, Joe-Marc Chauvin, Yiyang Wang, Ashley V. Menk, Chandra Nath Roy, Rashmi Srivastava, Frank P. Vendetti, Nicole E. Scharping, Weizhou Hou, Lulu Shao
Supplementary Figure S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a707a925bb3118d4a3df3e9885566d1c
https://doi.org/10.1158/2326-6066.22542367
https://doi.org/10.1158/2326-6066.22542367
Autor:
Saumendra N. Sarkar, Greg M. Delgoffe, Christopher J. Bakkenist, Hassane M. Zarour, Veit Hornung, Stephen H. Thorne, Pooja Karukonda, Joe-Marc Chauvin, Yiyang Wang, Ashley V. Menk, Chandra Nath Roy, Rashmi Srivastava, Frank P. Vendetti, Nicole E. Scharping, Weizhou Hou, Lulu Shao
Supplementary Figure S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90463aa2431d93b5087a8484a0567a2d
https://doi.org/10.1158/2326-6066.22542364.v1
https://doi.org/10.1158/2326-6066.22542364.v1
Autor:
Saumendra N. Sarkar, Greg M. Delgoffe, Christopher J. Bakkenist, Hassane M. Zarour, Veit Hornung, Stephen H. Thorne, Pooja Karukonda, Joe-Marc Chauvin, Yiyang Wang, Ashley V. Menk, Chandra Nath Roy, Rashmi Srivastava, Frank P. Vendetti, Nicole E. Scharping, Weizhou Hou, Lulu Shao
Supplementary Figure S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b7da510becdd4826410ceb2f333b76
https://doi.org/10.1158/2326-6066.22542370.v1
https://doi.org/10.1158/2326-6066.22542370.v1
Autor:
Saumendra N. Sarkar, Greg M. Delgoffe, Christopher J. Bakkenist, Hassane M. Zarour, Veit Hornung, Stephen H. Thorne, Pooja Karukonda, Joe-Marc Chauvin, Yiyang Wang, Ashley V. Menk, Chandra Nath Roy, Rashmi Srivastava, Frank P. Vendetti, Nicole E. Scharping, Weizhou Hou, Lulu Shao
Supplementary Figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15d77854966602f0497b01ef55305dcd
https://doi.org/10.1158/2326-6066.22542358
https://doi.org/10.1158/2326-6066.22542358
Publikováno v:
Mol Carcinog
Head and neck squamous cell carcinoma (HNSCC) poses significant treatment challenges, with high recurrence rates for locally advanced disease despite aggressive therapy typically involving a combination of surgery, radiation therapy, and/or chemother
Autor:
Saumendra N. Sarkar, Christopher J. Bakkenist, Hassane M. Zarour, Veit Hornung, rashmi Srivastava, Yiyang Wang, Weizhou Hou, Ashley V. Menk, Nicole E. Scharping, Lulu Shao, Joe-Marc Chauvin, Stephen H. Thorne, Pooja Karukonda, Chandra Nath Roy, Greg M. Delgoffe, Frank P. Vendetti
Publikováno v:
Cancer Immunology Research. 7:1258-1266
Multiple studies have associated the transcription factor IRF1 with tumor-suppressive activities. Here, we report an opposite tumor cell–intrinsic function of IRF1 in promoting tumor growth. IRF1-deficient tumor cells showed reduced tumor growth in
Autor:
Matthew Ballew, Saumendra N. Sarkar, Thomas P. Conrads, Greg M. Delgoffe, Mark J. O'Connor, Jan H. Beumer, R. Lalonde, David A. Clump, Brian F. Kiesel, Frank P. Vendetti, Pooja Karukonda, Troy P. Teo, Robert L. Ferris, Phuoc T. Tran, Katriana Nugent, Christopher J. Bakkenist
Publikováno v:
Journal of Clinical Investigation. 128:3926-3940
DNA-damaging chemotherapy and radiation therapy are integrated into the treatment paradigm of the majority of cancer patients. Recently, immunotherapy that targets the immunosuppressive interaction between programmed death 1 (PD-1) and its ligand PD-
Publikováno v:
Practical Radiation Oncology. 7:e551-e557
The results of Radiation Therapy Oncology Group (RTOG) 0617, which randomized patients with stages IIIA/IIIB non-small cell lung cancer (NSCLC) to definitive chemoradiation therapy to 60 Gy versus 74 Gy, demonstrated a detrimental survival impact wit